StrataXRT
StrataXRT is a medical device with 7 clinical trials. Currently 3 active trials ongoing. Historical success rate of 50.0%.
Success Metrics
Based on 2 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
UnknownTrial Status & Enrollment
50.0%
2 of 4 finished
50.0%
2 ended early
3
trials recruiting
7
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Study of StrataXRT in the Prevention of Radiation Dermatitis in Breast Cancer Patients
Efficacy Study With StrataXRT for the Prophylaxis of Radiation Dermatitis in Adjuvant Breast Radiation Treatment in Large Breasted Women Using a Prone Technique
StrataXRT vs Standard Clinical Practice for the Prevention of Acute Dermatitis in Head and Neck Cancers Patients
StrataXRT Versus Aquaphor for the Prevention and Management of Radiation Dermatitis
Feasibility in the Prophylaxis of Radiation Dermatitis Severity
Clinical Trials (7)
A Study of StrataXRT in the Prevention of Radiation Dermatitis in Breast Cancer Patients
Efficacy Study With StrataXRT for the Prophylaxis of Radiation Dermatitis in Adjuvant Breast Radiation Treatment in Large Breasted Women Using a Prone Technique
StrataXRT vs Standard Clinical Practice for the Prevention of Acute Dermatitis in Head and Neck Cancers Patients
StrataXRT Versus Aquaphor for the Prevention and Management of Radiation Dermatitis
Feasibility in the Prophylaxis of Radiation Dermatitis Severity
Retrospective Cohort Study Comparing a Novel Gel Dressing vs SoC in the Treatment of Radiation Dermatitis
StrataXRT vs. Standard Clinical Practice in the Prevention and Treatment of Radiation Dermatitis
All 7 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 7